Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Tardive Dyskinesia Therapeutics Global Market Report 2025
Download Free Sample Buy Now
Global Tardive Dyskinesia Therapeutics Market Report 2025
Item added to cart!

Published : December 2025

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Tardive Dyskinesia Therapeutics Global Market Report 2025

By Drug (Deutetrabenazine, Valbenazine, Other Drugs), By Product Type (Solid Dosage Forms, Tablets, Capsules, Liquid Dosage Form, Injection), By Application (Antipsychotic-Induced Tardive Dyskinesia, Other Drug-Induced Tardive Dyskinesia, Idiopathic Tardive Dyskinesia), By End-User (Hospitals, Clinics, Specialty Treatment Centers, Homecare Settings) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Tardive Dyskinesia Therapeutics Market?

Tardive dyskinesia therapeutics involve treatments designed to reduce or manage the uncontrollable, repetitive movements associated with this neurological disorder. These therapies are developed to target the underlying neurological imbalances often associated with prolonged use of certain medications. The goal is to improve patient quality of life by reducing the severity and frequency of motor disturbances, restoring functional abilities, and minimizing long-term complications.

The main drugs of tardive dyskinesia therapeutics are deutetrabenazine, valbenazine, and others. Deutetrabenazine is a vesicular monoamine transporter type 2 (VMAT2) inhibitor used as a medication to manage involuntary movements associated with tardive dyskinesia. It offers various product types including solid dosage forms, tablets, capsules, liquid dosage form, and injection and is applied for antipsychotic-induced tardive dyskinesia, other drug-induced tardive dyskinesia, and idiopathic tardive dyskinesia. It is used by several end-users such as hospitals, clinics, specialty treatment centers, and homecare settings.

Tardive Dyskinesia Therapeutics Market Size and growth rate 2025 to 2029: Graph

What Is The Tardive Dyskinesia Therapeutics Market Size 2025 And Growth Rate?

The tardive dyskinesia therapeutics market size has grown strongly in recent years. It will grow from $2.9 billion in 2024 to $3.12 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to rising prevalence of tardive dyskinesia, growing global population of patients with schizophrenia and bipolar disorder, increasing awareness and diagnosis, rising use of atypical and typical antipsychotic drugs, growing elderly population.

What Is The Tardive Dyskinesia Therapeutics Market Growth Forecast?

The tardive dyskinesia therapeutics market size is expected to see strong growth in the next few years. It will grow to $4.11 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to rising mental health disorder burden, expanding research and development activities, increasing investment by pharmaceutical companies, growing preference for personalized medicine, improved healthcare infrastructure. Major trends in the forecast period include collaborations between pharma companies and research institutes for novel therapies, development of extended-release formulations, emergence of generics, regulatory incentives such as orphan drug designation, technological advancements in drug delivery systems.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

How Is The Tardive Dyskinesia Therapeutics Market Segmented?

The tardive dyskinesia therapeutics market covered in this report is segmented –

1) By Drug: Deutetrabenazine, Valbenazine, Other Drugs

2) By Product Type: Solid Dosage Forms, Tablets, Capsules, Liquid Dosage Form, Injection

3) By Application: Antipsychotic-Induced Tardive Dyskinesia, Other Drug-Induced Tardive Dyskinesia, Idiopathic Tardive Dyskinesia

4) By End-User: Hospitals, Clinics, Specialty Treatment Centers, Homecare Settings

Sub Segments:

1) By Deutetrabenazine: Dosage Forms, Line Of Therapy, Distribution Channel

2) By Valbenazine: Dosage Forms, Patient Age Group, Distribution Channel

3) By Other Drugs: Drug Class Or Type, Dosage Forms, Treatment Duration

What Is Driving The Tardive Dyskinesia Therapeutics Market? Rising Mental Health Disorders Driving The Growth Of The Market Due To Increasing Use Of Long-Term Antipsychotics

The increasing prevalence of mental health disorders is expected to propel the growth of the tardive dyskinesia therapeutics market going forward. Mental health disorders are conditions that affect a person’s thoughts, emotions, behavior, or functioning, often causing significant distress or difficulty in daily life. Mental health disorders are rising due to increasing social isolation, as the shift toward digital communication and fast-paced lifestyles has reduced meaningful in-person connections, resulting to greater feelings of loneliness and emotional strain. Tardive dyskinesia therapeutics support mental disorder patients by managing involuntary movement symptoms caused by long-term antipsychotic use, thereby improving treatment adherence and overall quality of life. For instance, in 2024, according to the National Alliance On Mental Illness, a US-based organization, among people in the U.S. aged 18-44, psychosis spectrum and mood disorders account for nearly 600,000 hospitalizations each year. Therefore, the increasing prevalence of mental health disorders drives the tardive dyskinesia therapeutics market.

Who Are The Major Players In The Global Tardive Dyskinesia Therapeutics Market?

Major companies operating in the tardive dyskinesia therapeutics market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Lundbeck A/S, Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Neurocrine Biosciences Inc., Luye Pharma Ltd., Lannett Co. Inc., SteriMax Inc., Zydus Cadila Healthcare Ltd., Adamas Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation, SOM Biotech Ltd., Addex Therapeutics

What Are The Key Trends Of The Global Tardive Dyskinesia Therapeutics Market? Advancements In Once-Daily Treatment Options Enhancing Consistent Drug Delivery And Patient Compliance

Major companies operating in the tardive dyskinesia therapeutics market are focusing on developing advanced products, such as once-daily treatment options, to help maintain more consistent drug levels in the body. Once-daily treatment options refer to medications or therapies that are designed to be taken just once per day, simplifying dosing schedules and improving patient adherence. For instance, in May 2024, Teva Pharmaceutical Industries Limited, an Israel-based biopharmaceutical company, announced the U.S. Food and Drug Administration (FDA) approval for AUSTEDO XR tablets for treating adults with tardive dyskinesia (TD) and Huntington’s disease (HD) chorea. The recent approval of AUSTEDO XR offers patients proven effectiveness in managing involuntary movements with the added convenience of a once-daily, single-pill dosage. This new formulation delivers clinically therapeutic doses confirmed by pivotal clinical trials. Additionally, it is now available in four different tablet strengths: 30 mg, 36 mg, 42 mg, and 48 mg.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Tardive Dyskinesia Therapeutics Market? Teva And Jiangsu Nhwa Partner To Expand AUSTEDO Access In China’s Neuro-Psychiatric Market

In February 2024, Teva Pharmaceutical Industries Limited, an Israel-based biopharmaceutical company, partnered with Jiangsu Nhwa Pharmaceutical Co. Ltd. in order to promote and distribute Teva's AUSTEDO. The collaboration aims to expand patient access to Teva’s AUSTEDO by utilizing Nhwa’s strong presence in China’s neuropsychiatric health market. AUSTEDO is recognized as the first VMAT2 inhibitor approved by the U.S. FDA for treating tardive dyskinesia and chorea linked to Huntington’s disease in adults. Jiangsu Nhwa Pharmaceutical Co. Ltd. is a China-based pharmaceutical company.

What Is The Regional Outlook For The Global Tardive Dyskinesia Therapeutics Market?

North America was the largest region in the tardive dyskinesia therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tardive dyskinesia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tardive dyskinesia therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Tardive Dyskinesia Therapeutics Market?

The tardive dyskinesia therapeutics market consists of revenues earned by entities by providing services such as drug discovery, clinical trial management, formulation services, and pharmacovigilance. The market value includes the value of related goods sold by the service provider or included within the service offering. The tardive dyskinesia therapeutics market also includes sales of adjunctive medications, patient monitoring devices, drug delivery systems, and screening tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Tardive Dyskinesia Therapeutics Industry?

The tardive dyskinesia therapeutics market research report is one of a series of new reports from The Business Research Company that provides tardive dyskinesia therapeutics market statistics, including tardive dyskinesia therapeutics industry global market size, regional shares, competitors with a tardive dyskinesia therapeutics market share, detailed tardive dyskinesia therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the tardive dyskinesia therapeutics industry. This tardive dyskinesia therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Author : Abhilash Pyata

Tardive Dyskinesia Therapeutics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $3.12 billion
Revenue Forecast In 2034 $4.11 billion
Growth Rate CAGR of 7.2% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The tardive dyskinesia therapeutics market covered in this report is segmented –
1) By Drug: Deutetrabenazine, Valbenazine, Other Drugs
2) By Product Type: Solid Dosage Forms, Tablets, Capsules, Liquid Dosage Form, Injection
3) By Application: Antipsychotic-Induced Tardive Dyskinesia, Other Drug-Induced Tardive Dyskinesia, Idiopathic Tardive Dyskinesia
4) By End-User: Hospitals, Clinics, Specialty Treatment Centers, Homecare Settings Sub Segments:
1) By Deutetrabenazine: Dosage Forms, Line Of Therapy, Distribution Channel
2) By Valbenazine: Dosage Forms, Patient Age Group, Distribution Channel
3) By Other Drugs: Drug Class Or Type, Dosage Forms, Treatment Duration
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Lundbeck A/S, Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Neurocrine Biosciences Inc., Luye Pharma Ltd., Lannett Co. Inc., SteriMax Inc., Zydus Cadila Healthcare Ltd., Adamas Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation, SOM Biotech Ltd., Addex Therapeutics
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Tardive Dyskinesia Therapeutics Market Characteristics

3. Tardive Dyskinesia Therapeutics Market Trends And Strategies

4. Tardive Dyskinesia Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Tardive Dyskinesia Therapeutics Growth Analysis And Strategic Analysis Framework

5.1. Global Tardive Dyskinesia Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Tardive Dyskinesia Therapeutics Market Growth Rate Analysis

5.4. Global Tardive Dyskinesia Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Tardive Dyskinesia Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Tardive Dyskinesia Therapeutics Total Addressable Market (TAM)

6. Tardive Dyskinesia Therapeutics Market Segmentation

6.1. Global Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Deutetrabenazine

Valbenazine

Other Drugs

6.2. Global Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Solid Dosage Forms

Tablets

Capsules

Liquid Dosage Form

Injection

6.3. Global Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antipsychotic-Induced Tardive Dyskinesia

Other Drug-Induced Tardive Dyskinesia

Idiopathic Tardive Dyskinesia

6.4. Global Tardive Dyskinesia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Specialty Treatment Centers

Homecare Settings

6.5. Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Deutetrabenazine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Dosage Forms

Line Of Therapy

Distribution Channel

6.6. Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Valbenazine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Dosage Forms

Patient Age Group

Distribution Channel

6.7. Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Drug Class Or Type

Dosage Forms

Treatment Duration

7. Tardive Dyskinesia Therapeutics Market Regional And Country Analysis

7.1. Global Tardive Dyskinesia Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Tardive Dyskinesia Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tardive Dyskinesia Therapeutics Market

8.1. Asia-Pacific Tardive Dyskinesia Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tardive Dyskinesia Therapeutics Market

9.1. China Tardive Dyskinesia Therapeutics Market Overview

9.2. China Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tardive Dyskinesia Therapeutics Market

10.1. India Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tardive Dyskinesia Therapeutics Market

11.1. Japan Tardive Dyskinesia Therapeutics Market Overview

11.2. Japan Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tardive Dyskinesia Therapeutics Market

12.1. Australia Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tardive Dyskinesia Therapeutics Market

13.1. Indonesia Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tardive Dyskinesia Therapeutics Market

14.1. South Korea Tardive Dyskinesia Therapeutics Market Overview

14.2. South Korea Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tardive Dyskinesia Therapeutics Market

15.1. Western Europe Tardive Dyskinesia Therapeutics Market Overview

15.2. Western Europe Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tardive Dyskinesia Therapeutics Market

16.1. UK Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tardive Dyskinesia Therapeutics Market

17.1. Germany Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tardive Dyskinesia Therapeutics Market

18.1. France Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tardive Dyskinesia Therapeutics Market

19.1. Italy Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tardive Dyskinesia Therapeutics Market

20.1. Spain Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tardive Dyskinesia Therapeutics Market

21.1. Eastern Europe Tardive Dyskinesia Therapeutics Market Overview

21.2. Eastern Europe Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tardive Dyskinesia Therapeutics Market

22.1. Russia Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tardive Dyskinesia Therapeutics Market

23.1. North America Tardive Dyskinesia Therapeutics Market Overview

23.2. North America Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tardive Dyskinesia Therapeutics Market

24.1. USA Tardive Dyskinesia Therapeutics Market Overview

24.2. USA Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tardive Dyskinesia Therapeutics Market

25.1. Canada Tardive Dyskinesia Therapeutics Market Overview

25.2. Canada Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tardive Dyskinesia Therapeutics Market

26.1. South America Tardive Dyskinesia Therapeutics Market Overview

26.2. South America Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tardive Dyskinesia Therapeutics Market

27.1. Brazil Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tardive Dyskinesia Therapeutics Market

28.1. Middle East Tardive Dyskinesia Therapeutics Market Overview

28.2. Middle East Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tardive Dyskinesia Therapeutics Market

29.1. Africa Tardive Dyskinesia Therapeutics Market Overview

29.2. Africa Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tardive Dyskinesia Therapeutics Market Competitive Landscape And Company Profiles

30.1. Tardive Dyskinesia Therapeutics Market Competitive Landscape

30.2. Tardive Dyskinesia Therapeutics Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Tardive Dyskinesia Therapeutics Market Other Major And Innovative Companies

31.1. Otsuka Pharmaceutical Co. Ltd.

31.2. Sun Pharmaceutical Industries Ltd.

31.3. Dr. Reddy’s Laboratories Ltd.

31.4. Lundbeck A/S

31.5. Amneal Pharmaceuticals Inc.

31.6. Lupin Pharmaceuticals Inc.

31.7. Neurocrine Biosciences Inc.

31.8. Luye Pharma Ltd.

31.9. Lannett Co. Inc.

31.10. SteriMax Inc.

31.11. Zydus Cadila Healthcare Ltd.

31.12. Adamas Pharmaceuticals Inc.

31.13. Mitsubishi Tanabe Pharma Corporation

31.14. SOM Biotech Ltd.

31.15. Addex Therapeutics

32. Global Tardive Dyskinesia Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tardive Dyskinesia Therapeutics Market

34. Recent Developments In The Tardive Dyskinesia Therapeutics Market

35. Tardive Dyskinesia Therapeutics Market High Potential Countries, Segments and Strategies

35.1 Tardive Dyskinesia Therapeutics Market In 2029 - Countries Offering Most New Opportunities

35.2 Tardive Dyskinesia Therapeutics Market In 2029 - Segments Offering Most New Opportunities

35.3 Tardive Dyskinesia Therapeutics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Tardive Dyskinesia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Deutetrabenazine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Valbenazine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Tardive Dyskinesia Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Tardive Dyskinesia Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Pfizer Inc. Financial Performance
  • Table 79: Johnson & Johnson Financial Performance
  • Table 80: AbbVie Inc. Financial Performance
  • Table 81: Novartis AG Financial Performance
  • Table 82: Teva Pharmaceutical Industries Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Tardive Dyskinesia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Deutetrabenazine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Valbenazine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Tardive Dyskinesia Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Tardive Dyskinesia Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Pfizer Inc. Financial Performance
  • Figure 79: Johnson & Johnson Financial Performance
  • Figure 80: AbbVie Inc. Financial Performance
  • Figure 81: Novartis AG Financial Performance
  • Figure 82: Teva Pharmaceutical Industries Ltd. Financial Performance

2025 Over-The-Counter (OTC) Diet Products Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Over-The-Counter (OTC) Diet Products Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Parathyroid Disease Treatment Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Parathyroid Disease Treatment Market Revenue Outlook: Strategic Insights and Forecast to 2029

Industry Forecast: PCSK9 Inhibitor Market to Generate $6.87 Billion Revenue by 2029

Read More About Industry Forecast: PCSK9 Inhibitor Market to Generate $6.87 Billion Revenue by 2029

CAGR of 5.4% Projected for Pediatric Asthma Treatment Market From 2025 to 2029

Read More About CAGR of 5.4% Projected for Pediatric Asthma Treatment Market From 2025 to 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Leukemia Therapeutics Global Market Report 2025 – By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Other Treatments), By Type Of Leukemia (Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymp...

Bipolar Disorder Therapeutics Global Market Report 2025 – By Drug Class (Mood Stabilizers, Antipsychotic Drugs, Antidepressant Drugs, Other Drugs), By Mechanism (Selective Serotonin Reuptake Inhibitors, Serotonin-norepin...

Peptide Therapeutics Global Market Report 2025 – By Type (Generic, Branded), By Route of Administration (Parenteral, Mucosal, Oral, Transdermal), By Application (Cancer, Cardiovascular Diseases, Central Nervous Systems, ...

Liver Diseases Therapeutics Global Market Report 2025 – By Disease Type( Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcohol-Induced, Liver Cancer ), By Treatment( Antiviral, Vaccines, Chemotherapy, Immunosuppressive A...

Cystic Fibrosis (CF) Therapeutics Global Market Report 2025 – By Drug Class (Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, CFTR Modulators), By Route Of Administration (Oral, Inhaled), By Treatment Method (M...

Plasma Protein Therapeutics Global Market Report 2025 – By Product (Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products), By Route Of Administration (Intravenous, Subcutaneous), By Applica...

Post-Traumatic Stress Disorder Therapeutics Global Market Report 2025 – By Drug Class (Antidepressants, Anti-Anxiety, Antihypertensive, Monoamine Oxidase (MAOs), Antipsychotics Or Second Generation Antipsychotics (SGOs),...

Hypertrophic Cardiomyopathy (HCM) Therapeutics Global Market Report 2025 – By Drug Type (Antiarrhythmic Agents, Anticoagulants, Beta Adrenergic Blocking Agents, Calcium Channel Blockers, Other Drug Types), By Device Type...

Frequently Asked Questions

Tardive dyskinesia therapeutics involve treatments designed to reduce or manage the uncontrollable, repetitive movements associated with this neurological disorder. These therapies are developed to target the underlying neurological imbalances often associated with prolonged use of certain medications. The goal is to improve patient quality of life by reducing the severity and frequency of motor disturbances, restoring functional abilities, and minimizing long-term complications. For further insights on the Tardive Dyskinesia Therapeutics market, request a sample here

The Tardive Dyskinesia Therapeutics market major growth driver - Rising Mental Health Disorders Driving The Growth Of The Market Due To Increasing Use Of Long-Term Antipsychotics. For further insights on the Tardive Dyskinesia Therapeutics market, request a sample here

The Tardive Dyskinesia Therapeutics market size has grown strongly in recent years. The tardive dyskinesia therapeutics market size has grown strongly in recent years. It will grow from $2.9 billion in 2024 to $3.12 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to rising prevalence of tardive dyskinesia, growing global population of patients with schizophrenia and bipolar disorder, increasing awareness and diagnosis, rising use of atypical and typical antipsychotic drugs, growing elderly population. The tardive dyskinesia therapeutics market size is expected to see strong growth in the next few years. It will grow to $4.11 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to rising mental health disorder burden, expanding research and development activities, increasing investment by pharmaceutical companies, growing preference for personalized medicine, improved healthcare infrastructure. Major trends in the forecast period include collaborations between pharma companies and research institutes for novel therapies, development of extended-release formulations, emergence of generics, regulatory incentives such as orphan drug designation, technological advancements in drug delivery systems. For further insights on the Tardive Dyskinesia Therapeutics market, request a sample here

The tardive dyskinesia therapeutics market covered in this report is segmented –
1) By Drug: Deutetrabenazine, Valbenazine, Other Drugs
2) By Product Type: Solid Dosage Forms, Tablets, Capsules, Liquid Dosage Form, Injection
3) By Application: Antipsychotic-Induced Tardive Dyskinesia, Other Drug-Induced Tardive Dyskinesia, Idiopathic Tardive Dyskinesia
4) By End-User: Hospitals, Clinics, Specialty Treatment Centers, Homecare Settings Sub Segments:
1) By Deutetrabenazine: Dosage Forms, Line Of Therapy, Distribution Channel
2) By Valbenazine: Dosage Forms, Patient Age Group, Distribution Channel
3) By Other Drugs: Drug Class Or Type, Dosage Forms, Treatment Duration For further insights on the Tardive Dyskinesia Therapeutics market, request a sample here

North America was the largest region in the tardive dyskinesia therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tardive dyskinesia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Tardive Dyskinesia Therapeutics market, request a sample here.

Major companies operating in the tardive dyskinesia therapeutics market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Lundbeck A/S, Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Neurocrine Biosciences Inc., Luye Pharma Ltd., Lannett Co. Inc., SteriMax Inc., Zydus Cadila Healthcare Ltd., Adamas Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation, SOM Biotech Ltd., Addex Therapeutics . For further insights on the Tardive Dyskinesia Therapeutics market, request a sample here.

Major trends in the Tardive Dyskinesia Therapeutics market include Advancements In Once-Daily Treatment Options Enhancing Consistent Drug Delivery And Patient Compliance. For further insights on the Tardive Dyskinesia Therapeutics market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Tardive Dyskinesia Therapeutics Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon